SARS-CoV-2 Plus ELITe MGB Assay EAU Submitted
The SARS-CoV-2 Plus ELITe MGB Assay is developed and manufactured in Bothell, Wash., and it uses RNase P as an endogenous control for increased test reliability.
Medical Device News Magazine reports breaking biotechnology news including new biotech developments, pharmaceuticals and more.
The SARS-CoV-2 Plus ELITe MGB Assay is developed and manufactured in Bothell, Wash., and it uses RNase P as an endogenous control for increased test reliability.
The new data demonstrates the increasing prevalence of essential tremor (ET) from 2010 to 2018; a high rate of depression and anxiety in patients with ET; and the safety and efficacy of Cala Trio when used in a real-world setting to treat ET.
SOFIE notes following U.S. Food and Drug Administration (“FDA”) approval, Lantheus will have a critical need for dependable and scalable manufacturing and distribution partners to support PyL™.
November 11, 2020 SARS-CoV-2 Real-time RT-PCR Assay received CE-IVD marking for the use of saliva as specimen type and the option to pool up to five
The test is available to health systems, providers, employers, and academic institutions alike.
The breakthrough rapid DnaNudge RT-PCR test is now open for online booking and is available by appointment only from DnaNudge’s flagship store in London’s Covent Garden, and will be available as an at-home, by-post service throughout the UK within weeks.